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a  b  s  t  r  a  c  t
ATP-sensitive  K+ (KATP)  channels  were  originally  described  in cardiomyocytes,  where  physiological  levels
of intracellular  ATP  keep  them  in  a closed  state.  Structurally,  these  channels  are composed  of pore-forming
inward  rectiﬁer,  Kir6.1  or Kir6.2,  and  a regulatory,  ATP-binding  subunit,  SUR1,  SUR2A or  SUR2B.  SUR1
and Kir6.2  form  pancreatic  type  of  KATP channels,  SUR2A  and  Kir6.2  form  cardiac  type  of  KATP channels,
SUR2B and Kir6.1  form  vascular  smooth  muscle  type of KATP channels.  The  presence  of SUR2B  has been
described  in  cardiomyocytes,  but its functional  signiﬁcance  and  role  has  remained  unknown.  Pretreat-
ment  with  phenylephrine  (100  nM)  for 24  h  increased  mRNA  levels  of  SUR2B  and  Kir6.2,  without  affecting
those  levels  of SUR1,  SUR2A  and  Kir6.1  in  embryonic  heart  H9c2  cells. Such  increase  was  associated  with
increased  K+ current  through  KATP channels  and  Kir6.2/SUR2B  protein  complexes  as  revealed  by  whole
cell  patch  clamp  electrophysiology  and  immunoprecipitation/Western  blotting  respectively.  Pretreat-
ment  with  phenylephrine  (100  nM)  generated  a  cellular  phenotype  that  acquired  resistance  to  chemical
hypoxia  induced  by  2,4-dinitrophenol  (DNP;  10  mM),  which  was  accompanied  by  increased  in  K+ cur-
rent  in response  to DNP  (10  mM).  Cytoprotection  afforded  by  phenylephrine  (100 nM)  was  abolished
by  infection  of  H9c2  cells  with  adenovirus  containing  Kir6.2AFA,  a mutant  form  of Kir6.2  with  largely
reduced  K+ conductance.  Taking  all together,  the  present  ﬁndings  demonstrate  that  the  activation  of 1-
adrenoceptors  up-regulates  SUR2B/Kir6.2  to  confer  cardioprotection.  This is  the  ﬁrst account  of  possible
physiological  role of  SUR2B  in cardiomyocytes.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
ATP-sensitive K+ (KATP) channels were originally described in
cardiomyocytes, where physiological levels of intracellular ATP
keep them in a closed state. Upon a fall in intracellular ATP concen-
tration, as it happens during ischaemia/hypoxia, the channels are
released from inhibition, leading to hyperpolarisation and short-
ening of action membrane potential to inhibit voltage operated
Ca2+ channels and prevent intracellular Ca2+ overload, which is
the main cause of cardiomyocytes death under adverse conditions
∗ Corresponding author at: Medical Research Institute, Division of Cardiovascular
&  Diabetic Medicine, Ninewells Hospital & Medical School, University of Dundee,
Dundee DD1 9SY, Scotland, UK.
E-mail address: a.jovanovic@dundee.ac.uk (A. Jovanovic´).
(reviewed by Nichols, 2006). Structurally, KATP channels are com-
posed of pore-forming inward rectiﬁer, Kir6.1 or Kir6.2, and a
regulatory, ATP-binding subunit, SUR1, SUR2A or SUR2B. It is
generally accepted that four Kir6.x and four SURx are physically
associated with each other to form functional KATP channels. The
properties of these channels are different in various tissues due to
the combinations of the subunits forming the channel. SUR1 and
Kir6.2 form pancreatic type of KATP channels, SUR2A and Kir6.2
form cardiac type of KATP channels, SUR2B and Kir6.1 form vas-
cular smooth muscle type of KATP channels and others (Nichols,
2006). There are studies suggesting that further diversity may  be
generated by combination of more than one type of Kir6.x and SURx
subunits within an individual channel (Flagg et al., 2010). All chan-
nel subunits have been found in the heart (Du et al., 2006; Zhou
et al., 2007; Flagg et al., 2010), but it seems that expression varies
from region to region and can change under pathophysiological
http://dx.doi.org/10.1016/j.biocel.2015.10.029
1357-2725/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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conditions (Arakel et al., 2014). In the heart, the activation and
trafﬁcking of sarcolemmal KATP channels mediate ischaemic pre-
conditioning, a phenomenon when a brief period of blood vessel
occlusion enhances the survival of cardiac cells under conditions
that induce myocardial infarction (Budas et al., 2004; Sukhodub
et al., 2007).
H9c2 cells are embryonic rat heart cell line that was used with
success to study KATP channels and cardioprotection (reviewed by
Jovanovic´ and Jovanovic´, 2007). These cells express Kir6.1, Kir6.2,
SUR1, SUR2A and SUR2B subunits, as adult cardiomyocytes do (Du
et al., 2006, 2010a; Zhou et al., 2007; Ballantyne et al., 2013). In
adult hearts/cardiomyocytes and H9c2 cells, it has been demon-
strated that increased SUR2A levels confer cardioprotection by
increasing levels of SUR2A-containing KATP channels (Du et al.,
2006, 2010a,b; Mohammed Abdul et al., 2014, 2015a,b). In con-
trast, knock-out of SUR1 induces cardioprotection (Lefer et al.,
2009). Although SUR2B is expressed in adult cardiomycoytes as
well as in H9c2 cells (Du et al., 2006, 2010a; Zhou et al., 2007),
no functional role for SUR2B-containing KATP channels has been
uncovered. One possible reason why there is no more data about
SUR2B in cardiomyocytes could be due to the fact that electro-
physiological properties between SUR2A/Kir6.2 and SUR2B/Kir6.2
are indistinguishable (Fujita and Kurachi, 2000) and that it is usual
assumption that SUR2A/Kir6.2 is the main sarcolemmal KATP chan-
nel form and, consequently, all KATP channels-mediated effects are
usually ascribed to SUR2A/Kir6.2.
It is well established that pretreatment with 1-adrenoceptor
agonist, phenylephrine, induces preconditioning by increasing KATP
channels-mediated current (Turrell et al., 2011). This effect of
phenylephrine could be mediated not only by the activation of KATP
channels, but also by their increased presence in plasma membrane,
as it has been already described for ischaemic preconditioning
(Budas et al., 2004; Sukhodub et al., 2007). In the present study we
used H9c2 cells to examine whether pretreatment with phenyle-
phrine would affect the expression of KATP channels. We  found that
it would, but not in a way we expected. Phenylephrine increased
SUR2B/Kir6.2, without affecting SUR2A levels, to confer cytopro-
tection. This is the ﬁrst report ever demonstrating physiological
importance and functional role of SUR2B in cardiomyocytes.
2. Materials and methods
2.1. H9c2 cells
Rat embryonic heart H9c2 cells (ECACC, Salisbury, UK) were
cultured in a tissue ﬂask (at 5% CO2) containing Dulbecco’s mod-
iﬁed Eagle’s medium supplemented with 10% fetal calf serum
and 2 mM glutamine as described (Du et al., 2010a). Brieﬂy,
for electrophysiological experiments, the cells were plated on a
35 mm × 10 mm culture dish containing 25-mm glass cover-slips.
The cells were cultured in incubators (Galaxy, oxygen control
model, RS Biotech, Irvine, UK). Some cells were treated with
phenylephrine (100 nM)  or vehicle (methanol) for 24 h. For some
experiments H9c2 cells were infected with adenoviral constructs
containing either luciferase (cells infected with luciferase have
served as control cells in this study) or Kir6.2AFA (a mutant form of
Kir6.2 where the pore GFG was mutated into AFA leading to largely
reduced K+ conductance).
2.2. Real time RT-PCR
Real time RT-PCR was performed as described previously (Du
et al., 2006, 2010a,b). In brief, total RNA was extracted from H9c2
cells using TRIZOL reagent (Invitrogen, Carlsbad, CA) according to
the manufacturer’s recommendations. Extracted RNA was further
puriﬁed by RNeasy Plus Mini Kit (Qiagen, Crawley, UK) according
to the manufacturer’s instructions. The primers had the following
sequences. For SUR1 sense – 5′-GGAAGGACTCACCCCATC-3′
and for antisense – 5′-GAGACCATCAAGGCATA GG-3′. For
SUR2A sense – 5′-ACTTCAGCGTTGGACAGAGAC-3′ and for
antisense – 5′-AGCAAGGTTTGGACCAGTATCG-3′. For SUR2B
sense – 5′-GACGCCACT GTCACCGAAG-3′ and for antisense
– 5′-TCATCACAATGACCA GGTCAGC-3′. For Kir6.1 sense
– 5′-GTCACACGCTGGTCATCTTCAC-3′ and for antisense –
5′-GGCACTCCTCAGTCATCATTCTCC-3′. For Kir6.2 sense –
5′-TGGCTGACGAGATTCTGTGG-3′ and for antisense – 5′-
TGGCGGGCTG TGCAGAG-3′. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as a control and for GAPDH
sense – 5′-ATA GAATTCC ATGACAAAGTGGACATTGTTGCCA-3′ and
for antisense – 5′-AGCCT CGAGTTAGGAAATGAG CTTCACAAAGTT-
3′. The reverse transcription (RT) reaction was carried out with
ImProm-II Reverse Transcriptase (Promega, Southampton, UK).
A ﬁnal volume of 20 l of RT reaction containing 4 l of 5×
buffer, 3 mM MgCl2, 20 U of RNasin® Ribonuclease inhibitor, 1 U of
ImProm-II reverse transcriptase, 0.5 mM each of dATP, dCTP, dGTP,
and dTTP, 0.5 g of oligo(dT), and 1 g of RNA was  incubated at
42 ◦C for 1 h and then inactivated at 70 ◦C for 15 min. The resulting
cDNA was used as a template for real-time PCR. A SYBR Green I
system was used for the RT-PCR and the 25 l reaction mixture
contained: 12.5 l of iQTM SYBR® Green Supermix (2×),  7.5 nM
each primers, 9 l of ddH2O, and 2 l of cDNA. In principle, the
thermal cycling conditions were as follows: an initial denaturation
at 95 ◦C for 3 min, followed by 40 cycles of 10 s of denaturing at
95 ◦C, 15 s of annealing at 56 ◦C, and 30 s of extension at 72 ◦C.
The real-time PCR was  performed in the same wells of a 96-well
plate in the iCycler iQTM Multicolor Real-Time Detection System
(Bio-Rad, Hercules, CA). Data was  collected following each cycle
and displayed graphically (iCycler iQTM Real-time Detection Sys-
tem Software, version 3.0A, BioRad, Hercules, CA). Primers were
tested for their ability to produce no signal in negative controls by
dimer formation and then with regard to the efﬁciency of the PCR.
Efﬁciency is evaluated by the slope of the regression curve obtained
with several dilutions of the cDNA template. Melting curve anal-
ysis tested the speciﬁcity of primers. Threshold cycle values, PCR
efﬁciency (examined by serially diluting the template cDNA and
performing PCR under these conditions) and PCR speciﬁcity (by
constructing the melting curve) were determined by the same soft-
ware, as described in Du et al. (2010a). The calculation of relative
mRNA expression was performed as described (Sudhir et al., 2011).
The relative expression ratio (R) of gene encoding channel subunits
is calculated using equation R = (EK)CPK(C-P)/(ER)CPR(C-P), where
EK is the real time PCR efﬁciency of a gene of interest transcript,
ER is the real time PCR efﬁciency of a reference gene (GAPDH;
we have shown that this gene is not affected by phenylephrine),
CPK is the crossing point deviation of control (C)–phenylephrine
(P) of gene of interest transcript while CPR is the crossing point
deviation of control (C)–phenylephrine (P) of a reference gene
transcript. All primers and conditions applied in the present study
have been fully validated previously (Du et al., 2010a; Sudhir et al.,
2011).
2.3. Patch clamp electrophysiology
To monitor whole cell K+ current the giagaohm seal patch-
clamp technique was  applied in the traditional or perforated-patch
whole cell conﬁguration. For whole-cell electrophysiology cells
were superfused with Tyrode solution (in mM:  136.5 NaCl; 5.4
KCl; 1.8 CaCl2; 0.53 MgCl2; 5.5 glucose; 5.5 HEPES–NaOH; pH 7.4).
Pipettes (resistance 3–5 M)  were ﬁlled with (in mM):  KCl 140,
MgCl2 1, ATP 0.005 (low ATP was present to prevent run-down
of the channel without signiﬁcantly affecting channel activity),
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HEPES–KOH 5 (pH 7.3). For perforated patch clamp electrophysiol-
ogy, the same solutions were used just ATP was completely omitted
and amphotericin B (Sigma, 240 g/ml) added (Du et al., 2010a).
For all cells monitored, the membrane potential was  normally held
at −40 mV  and the currents evoked by a series of 400 ms  depo-
larising and hyperpolarising current steps (−40 mV  to +80 mV  in
20 mV steps) recorded directly to hard disk using anAxopatch-200B
ampliﬁer, Digidata-1321 interface and pClamp8 software (Axon
Instruments, Inc., Forster City, CA). The capacitance compensation
was adjusted to null the additional whole-cell capacitative cur-
rent. The slow capacitance component measured by this procedure
was used as an approximation of the cell surface area and allowed
normalisation of current amplitude (i.e. current density). Currents
were low pass ﬁltered at 2 kHz and sampled at 100 s intervals, as
described in Du et al. (2010a).
2.4. Immunoprecipitation/Western blotting
Immunoprecipitation/Western blotting was performed as pre-
viously described (Du et al., 2006, 2010a). To obtain cellular
membrane fraction cells were homogenised in buffer I (Tris 10 mM,
NaH2PO4 20 mM,  EDTA 1 mM,  PMSF 0.1 mM,  pepstatin 10 g/ml,
leupeptin 10 g/ml, at pH = 7.8) and incubated for 20 min  (at 4 ◦C).
The osmolarity was restored with KCl, NaCl and sucrose and the
obtained mixture was centrifugated at 500 × g. The supernatant
was diluted in buffer II (imidazole 30 mM,  KCl 120 mM,  NaCl
30 mM,  NaH2PO4 20 mM,  sucrose 250 mM,  pepstatin 10 g/ml,
leupeptin 10 g/ml, at pH = 6.8) and centrifugated at 7000 × g,
pellet removed and supernatant centrifugated at 30,000 × g. The
obtained pellet contains membrane fraction. Protein concentra-
tion was determined using the method of Bradford; 10 g of the
anti-Kir6.2 antibody was prebound to Protein-G Sepharose beads
and used to immunoprecipitate from 50 g of membrane fraction
protein extract. The pellets of this precipitation were run on SDS-
polyacrylamide gels for Western analysis. Western blot probing
was performed using 1/1000 dilution of anti-SUR2B antibody, and
detection was achieved using Protein-G HRP and ECL reagents. The
band intensities were analyzed using the Quantiscan software.
2.5. Cell survival assay
The survival of H9c2 cells was assayed using Multitox-Fluor
Multiplex Cytotoxicity Assay (Promega). Brieﬂy, H9c2 cells were
plated in complete media (DMEM containing 10% FCS) in 96-well
plate. After incubation period (24 h), the DNP was  added to each
well at the ﬁnal concentration of 10 mM.  To measure cell survival
6 h later, the peptide substrate (GF-AFC) that can be cleaved only by
live cells was added to the each well. Following 30 min-long incuba-
tion at 37 ◦C, plates were measured using 1420 Multibabel Counter
(Victor) plate reader, with excitation at 370 nm and emissions of
480 nm.  The percentage of live cells was calculated based on the
intensity of ﬂuorescence according to the manufacturer instruc-
tions, as described in Du et al. (2010a).
2.6. Statistical analysis
Data are presented as mean ± SEM, with n representing the
number of cells (for electrophysiology) or independent experi-
ments (for real time RT-PCR and cell survival assay). Mean values
were compared by Student’s t-test using SigmaStat program (Jan-
del Scientiﬁc, Chicago, Illinois). P < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Pretreatment with phenylephrine increases SUR2B/Kir6.2
24 h-long treatment of H9c2 cells with phenylephrine (100 nM)
did not affect mRNA levels of SUR1 (cycling threshold was
28.65 ± 0.22 for control and 28.12 ± 0.13 for phenylephrine-
pretreated cells, P = 0.069; n = 6; Fig. 1AA1), SUR2A (cycling
threshold was  28.60 ± 0.09 for control and 28.12 ± 0.15 for
phenylephrine-pretreated cells, P = 0.131; Fig. 1AA1) and Kir6.1
(cycling threshold was  18.56 ± 0.21 for control and 18.25 ± 0.06
for phenylephrine-pretreated cells, P = 0.209; n = 6; Fig. 1AA1).
On the other hand, this treatment signiﬁcantly increased lev-
els of SUR2B and Kir6.2 mRNAs (SUR2B: cycling threshold
was 20.92 ± 0.05 for control and 20.28 ± 0.05 for phenylephrine-
pretreated cells, P < 0.001; n = 6; Fig. 1AA1; Kir6.2: cycling
threshold was 27.40 ± 0.10 for control and 26.40 ± 0.10 for
phenylephrine-pretreated cells, P < 0.001; n = 6; Fig. 1AA1). The
level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) that
we used as a housekeeping gene was not affected by 100 nM
phenylephrine (cycling threshold was 11.05 ± 0.14 for control and
11.01 ± 0.11 for phenylephrine-pretreated cells, P = 0.601; n = 6;
Fig. 1A). In H9c2 cells pretreated with phenylephrine (100 nM),
K+ current density was  signiﬁcantly increased (current density
at +80 mV  was  2.3 ± 0.2 pApF for control and 3.8 ± 0.3 pApF for
phenylephrine-pretreated cells; P < 0.001; n = 5; Fig. 1BB1). West-
ern blotting signal obtained by anti-SUR2B antibody on anti-Kir6.2
immunoprecipitate was  signiﬁcantly stronger in H9c2 cells treated
with phenylephrine (100 nM)  than in untreated ones (Fig. 1C).
3.2. Pretreatment with phenylephrine improves the outcome of
chemical hypoxia
To determine whether increased number of functional
SUR2B/Kir6.2 channels alters in any way  cellular resistance to
stress, we have used DNP, an inhibitor of oxidative phosphory-
lation. 26.8 ± 0.8% of control cells survived challenge with DNP
(10 mM;  Fig. 2A) which was signiﬁcantly lower than those in cells
pretreated with 100 nM phenylephrine (32.5 ± 0.6% cells survived
challenge with DNP, P < 0.001, n = 6, Fig. 2A). At the same time, DNP
(10 mM)  induced signiﬁcantly larger K+ current in cells pretreated
with phenylephrine (100 nM)  than those in control cells (current
density at +80 mV  was 3.1 ± 0.2 pApF for control and 3.9 ± 0.3 pApF
for phenylephrine-pretreated cells; P < 0.001; n = 6; Fig. 2BB1).
3.3. Kir6.2AFA inhibits cytoprotection afforded by phenylephrine
To establish a causal relationship between channels opening
and cytoprotection afforded by phenylephrine, we have tested the
effect of Kir6.2AFA. This is a mutant form of Kir6.2 with largely
reduced K+ conductivity (Du et al., 2010a). We have found out
that H9c2 cells expressing Kir6.2AFA cannot be preconditioned by
phenylephrine as cell survival was  25.1 ± 2.9%, which was not sig-
niﬁcantly different from those in control cells (cell survival was
23.6 ± 1.6%, P = 0.611, n = 6; Fig. 3).
4. Discussion
H9c2 cells are well-established experimental model that is sim-
ilar to adult cardiomyocytes in crucial aspects of KATP channels
structure, physiology and function. It has been shown that both cell
types express all ﬁve KATP channel subunits (Du et al., 2006, 2010a;
Zhou et al., 2007) and that increased levels of SUR2A increase num-
bers of fully functional KATP channels resulting in a phenotype more
resistant to stress (Du et al., 2006, 2010a). Signalling pathways
regulating KATP channel levels and mediating preconditioning and
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Fig. 1. Pretreatment with phenylephrine up-regulate SUR2B/Kir6.2 leading to increase in number of functional KATP channels. (A) Bar graphs representing cycling threshold of
the  real time RT-PCR progress curves of KATP channel-forming subunits. Each bar represents mean ± SEM (n = 6). *P < 0.05. (A1) Relative expression ratio (control/phenylephrine
ratio  of mRNA levels calculated from data shown in A) of KATP channel subunits (as depicted on the graph). Each bar represents mean ± SEM (n = 6). (B) Original whole cell
membrane currents for cells kept under control conditions (control) and pretreated with phenylephrine (100 nM). (B1) Bar graphs of K+ current density at +80 mV under
conditions corresponding to (B). Each bar represents mean ± SEM (n = 5). *P < 0.05. (C) Original Western blots with anti-SUR2B antibody of anti-Kir6.2 immunoprecipitate
pellets  from membrane fractions obtained from H9c2 cells under control conditions and when pretreated with phenylephrine (100 nM)  and corresponding graph. Each bar
represents mean ± SEM (n = 3–4). *P < 0.05.
cardioprotection are similar between adult cardiomyocytes and
H9c2 cells (Ranki et al., 2002; Crawford et al., 2003; Qu et al., 2010;
Du et al., 2010a,b; Mohammed Abdul et al., 2015a,b; Kuznetsov
et al., 2015). Both cell types respond similarly to an inhibitor of
oxidative phosphorylation, DNP (Jovanovic´ et al., 1998, 2009a,b;
Jovanovic´ and Jovanovic´, 2001a; Du et al., 2010a), which seems
to be a good experimental model to study myocardial response to
ischaemia/ischaemia-reperfusion and cardioprotection (Jovanovic´
and Jovanovic´, 2007). SUR2A and SUR2B are splicing variants of
the same ABCC9 gene (Nichols, 2006; Flagg et al., 2010). While
SUR2A is the main cardiac responder to a range of hormones and
physiological stimuli including estrogens, physical activity, age-
ing and oxygen, no cardiac role/function has been ascribed for
SUR2B, a protein that is recognized mainly as a regulatory sub-
unit of vascular type of KATP channels (Nichols, 2006; Flagg et al.,
2010). Cardiac preconditioning afforded by 1-adrenoceptor ago-
nist is mediated via AMPK (Turrell et al., 2011), which is known
to increase the number of sarcolemmal KATP channels (Sukhodub
et al., 2007). As the rate limiting factor in functional channel forma-
tion is availability of SUR2A (Du et al., 2006; Sukhodub et al., 2010,
2011), we  have expected that phenylephrine could up-regulate
SUR2A. However, that was not the case and phenylephrine did
not affect expression of SUR1, SUR2A and Kir6.1. On the other
hand, phenylephrine increased mRNA levels of SUR2B and Kir6.2.
SUR2B and Kir6.2 can physically associate to form KATP channels
(Fujita and Kurachi, 2000). In the heart, SUR2B has been primarily
localized in subcellular structures, mitochondrias and endoplasmic
reticulum, although presence in the sarcolemma was  recognised
as well (Zhou et al., 2007). If increased SUR2B/Kir6.2 results
in more functional KATP channels in sarcolemma, patch clamp
electrophysiology should detect such change (Du et al., 2010b).
KATP channels are normally closed by millimolar intracellular ATP
(Nichols, 2006). To measure K+ current ﬂowing through KATP chan-
nels we  used traditional whole cell patch clamp electrophysiology
with small presence of ATP in the pipette solution. Used amounts
of ATP were not sufﬁcient to signiﬁcantly inhibit channels opening,
but helped to keep channels in operative condition and prevent
channels run-down (Jovanovic´ and Jovanovic´, 2005). These mea-
surements demonstrated that cells pretreated with phenylephrine
exhibit increase in K+ current ﬂowing through KATP channels, which
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Fig. 2. Pretreatment with phenylephrine increases survival of cells and whole cell K+ current in response to DNP. (A) A bar graph showing a percentage of survival in control
cells  and cells pretreated with phenylephrine (100 nM)  exposed to DNP (10 mM).  Each bar represent mean ± SEM (n = 6). *P < 0.05. (B) Original perforated patch clamp whole
cell  membrane currents in response to DNP (10 mM)  for cells kept under control conditions (control) and pretreated with phenylephrine (100 nM). (B1) Bar graphs of K+
current density at +80 mV under conditions corresponding to (B). Each point represents mean ± SEM (n = 6). *P < 0.05.
supports the notion that up-regulation of SUR2B/Kir6.2 results in
increased number of functional channels in sarcolemma. Finally,
we have tested whether pretreatment with phenylephrine would
increase the levels of SUR2B that physically associate with Kir6.2.
To do that, we have applied immunoprecipitation with anti-Kir6.2
antibody followed by Western blotting, with anti-SUR2B antibody.
This strategy secures exclusive measurement of Kir6.2 and SUR2B
that physically interact with each other to form functional channels
(Ranki et al., 2001; Du et al., 2006, 2010a; Sukhodub et al., 2010,
2011). Signiﬁcantly stronger western blot signal was obtained
in cells pre-treated with phenylephrine suggesting that phenyle-
phrine increased the level of SUR2B/Kir6.2 in membrane of H9c2
cells. Thus, ﬁndings obtained by patch clamp electrophysiology
and immunoprecipitation/Western blotting support each other and
provide strong evidence in favor of the notion that phenylephrine
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Fig. 3. Kir6.2AFA inhibits cytoprotection afforded by phenylephrine. A bar graph
showing a percentage of survival in cells infected with Kir6.2AFA kept under control
conditions and pretreated with phenylephrine (100 nM)  exposed to DNP (10 mM).
Each bar represent mean ± SEM (n = 6).
increases the number of functional SUR2B/Kir6.2 KATP channels.
This is the ﬁrst demonstration of regulation of SUR2B-containing
KATP channels in heart cells.
DNP is an inhibitor of oxidative phosphorylation that is routinely
used to mimic  ischaemia and ischaemia-reperfusion injury and it
is often used to study cardioprotection (Jovanovic´ and Jovanovic´,
2007). We have found that phenylephrine-pretreated cells were
more resistant to DNP than the control ones, which was  associated
with increased K+ current in response to DNP. An increase in num-
ber of functional KATP channels is known to increase DNP-induced
K+ current mediating cytoprotection afforded by KATP channels (Du
et al., 2010a). Thus, the observed effect of DNP further conﬁrms that
treatment with phenylephrine increases the number of functional
channels that, in turn, mediate cytoprotection. Our current ﬁndings
are also in accord with a previous study demonstrating that precon-
ditioning afforded by phenylephrine was associated with increased
KATP channels-mediated K+ current (Turrell et al., 2011).
It is well established that activation of KATP channels is cyto-
protective even in cells that do not generate action membrane
potential, including H9c2 cells (Du et al., 2010a). Activation of
KATP channels hyperpolarize the membrane which, in turn, pre-
vents inﬂux of Ca2+ and consequent Ca2+ loading, which is the main
cause of cell death in stress (Jovanovic´ and Jovanovic´, 2001a,b). An
increase in number of KATP channels is associated with increased K+
current in response to challenge with DNP, which can be inhibited
by Kir6.2AFA, a mutant form of Kir6.2 of largely reduced K+ con-
ductivity (Jovanovic´ et al., 2009a,b; Du et al., 2010a). We  have
found out that H9c2 cells expressing Kir6.2AFA cannot be pre-
conditioned by phenylephrine, which strongly supports the notion
that the observed cardioprotection is mediated by increase in KATP
channels.
SUR2B is a subunit found primarily in smooth muscle cells,
although their presence was  reported in other cell types as well
(Nichols, 2006; Flagg et al., 2010; Du et al., 2010b). In cardiomy-
ocytes, their presence was  detected, but functional role was not
understood. Here, we have found that SUR2B physically associate
with Kir6.2 to act as a regulatory subunit in sarcolemmal KATP
channels to confer cardioprotection. What would be a signiﬁcance
of SUR2B-containing KATP channels in cardiomyocytes? There is
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not much difference in electrophysiological properties between
SUR2A/Kir6.2 and SUR2B/Kir6.2, but there are some differences
in sensitivity towards certain ligands. As an example, in the pres-
ence of Mg2+ SUR2B/Kir6.2 is slightly more sensitive to intracellular
ATP, while in the absence of Mg2+ is otherway around. It is also
known that SUR2B/Kir6.2 can be activated by diazoxide, which is
not the case with SUR2A/Kir6.2 (Fujita and Kurachi, 2000). In addi-
tion to that, it is known that SUR2A/Kir6.2 physically associate with
adenylate kinase, creatine kinase and glycolytic enzymes in vivo
(Carrasco et al., 2001; Crawford et al., 2002a,b; Jovanovic´ et al.,
2005; Hong et al., 2011). These enzymes are crucial for the chan-
nel regulation during ischaemia/hypoxia and for ATP production,
which also seems to contribute to cytoprotection (Jovanovic´ et al.,
2009a,b). Whether SUR2B/Kir6.2 protein complex interact with
the same enzymes as SUR2A/Kir6.2 do it is yet to be determined,
but some differences are probable. Consequently, up-regulation
of SUR2B/Kir6.2 would have different physiological outcome from
up-regulation of SUR2A/Kir6.2. It seems that the activation of 1-
adrenoceptors creates a unique cardiac phenotype in terms of KATP
channels expression as other factors such as hypoxia, exercise,
estrogens and ageing affect mainly SUR2A-containing KATP chan-
nels.
Taking all together, the present ﬁndings demonstrate that acti-
vation of 1-adrenoceptors up-regulates SUR2B/Kir6.2 to confer
cardioprotection. This is the ﬁrst account of possible physiological
role of SUR2B in cardiomyocytes.
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